The human aspect is vital
Wilco Alblas, Vice President Customer Operations, Sakura Finetek Europe, comments: “After years of implementing instruments, Sakura gained the knowledge, tools and resources to realise histopathology laboratories’ visions. We understand that the human aspect is vital in bringing your laboratory into the future. No two labs are the same. Our team of experts guide transitions with the proven Sakura Bridge-methodology, placing the key focus on lab staff.”
“Implementing a continuous flow in a laboratory is challenging and that human aspect is vital. You have to change your processes to get the results you desire. As a company, we have committed to achieving your laboratory’s goals with you. With Sakura Bridge, we take over the challenging aspects of change and ensure optimal results by connecting technology and people.”
More about Sakura Finetek Europe
When it comes to diagnosing cancer, there’s no time to wait. At Sakura Finetek Europe, our drive is our desire to advance cancer diagnoses through fully automated anatomic pathology. We advance cancer diagnostics by providing integrated solutions for anatomic pathology and patients, through best-in-class innovations, quality and customer care. Sakura is the original manufacturer of Tissue-Tek®, Cyto-Tek®, Tissue-Tek VIP® and Tissue-Tek Xpress®, today’s industry standards. With headquarters based in Alphen aan den Rijn (NL) and seven regional locations in Europe, we empower pathology professionals in the EMEAI region to deliver accurate and fast diagnoses to optimise treatment success for each life we touch. Sakura’s Bridge implementation consultancy service is directly available via your local Sakura contact point. For more information, go to www.Sakura.eu/bridge, follow us on LinkedIn.